A dual kinase inhibitor* is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine as part of Cancer Research UK’s Combinations Alliance. The novel combination of drugs targets the process of nerve invasion, observed in over 80% of pancreatic ductal adenocarcinoma…
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment. They say the decision will benefit approximately 2,100 patients a year.
Read more at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2019-05-17-cancer-drug-approved-for-nhs-use-in-england-gives-some-multiple-myeloma-patients-another-option
Grace Li
New from News Digest this week: follow with new breakthroughs and research on bowel cancer rates, brain tumor "pink drink", cigarette displays and chewing gum.
Read more at: https://scienceblog.cancerresearchuk.org/2019/05/18/news-digest-bowel-cancer-rates-brain-tumour-pink-drink-cigarette-displays-and-chewing-gum/